专题:Psychedelics and Drug Studies

This cluster of papers explores the therapeutic potential of psychedelic therapy, particularly focusing on the use of substances like psilocybin and MDMA for the treatment of depression, anxiety, and substance dependence. The research delves into the neurobiology, serotonin receptors, and brain function underlying the effects of these psychedelics, as well as their ability to induce mystical experiences and promote long-lasting positive changes in psychological functioning.
最新文献
近5年高被引文献
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

article Full Text OpenAlex 1125 FWCI172.0037

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder

article Full Text OpenAlex 687 FWCI106.7802

Novel and emerging treatments for major depression

article Full Text OpenAlex 588 FWCI79.3827

Single-Dose Psilocybin Treatment for Major Depressive Disorder

article Full Text OpenAlex 514 FWCI135.5404

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

article Full Text OpenAlex 486 FWCI128.1569

Psychedelics promote plasticity by directly binding to BDNF receptor TrkB

article Full Text OpenAlex 459 FWCI121.037

Increased global integration in the brain after psilocybin therapy for depression

article Full Text OpenAlex 439 FWCI72.864

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

article Full Text OpenAlex 426 FWCI70.6277

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial

article Full Text OpenAlex 423 FWCI111.2802

Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial

article Full Text OpenAlex 350 FWCI57.7694